Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 38 P319 | DOI: 10.1530/endoabs.38.P319


The accuracy of bilateral inferior petrosal sinus cannulation and usefulness of prolactin adjustment in one Scottish centre

Kerri Devine2, Karen Smith3, Iain Robertson1, Colin Perry1 & Marie Freel1


1South Glasgow University Hospital, Glasgow, UK; 2Wishaw General Hospital, Lanarkshire, UK; 3Glasgow Royal Infirmary, Glasgow, UK.

Bilateral inferior petrosal sinus sampling (BIPSS) is the gold standard investigation in Cushing’s disease for identifying the pituitary as the ACTH source. This technique aims to demonstrate a gradient of central:peripheral ACTH levels of >2:1 in such patients, or >3:1 after CRH stimulation. In patients without significant pituitary MRI abnormalities this facilitates neurosurgical exploration.

The test is limited by difficulties in achieving adequate sinus cannulation in some patients. Sinus to peripheral prolactin ratio is being used in some centres to confirm cannulation and allow for result adjustment, with ratio >1.8 indicating success. The ‘prolactin-adjusted’ ACTH ratio may also guide adenoma lateralisation.

In our tertiary referral centre, between 2010 and 2015, 15 patients with confirmed ACTH-dependent Cushing’s underwent BIPSS with the addition of prolactin measurements from 2013. We aimed to demonstrate whether this modification improved the diagnostic yield by careful review of electronic case records of all fifteen patients.

Overall, 13 patients had definite pituitary Cushing’s disease; 12 subsequently confirmed on hypophysectomy and one with empty sella syndrome who underwent adrenalectomies. Two of 15, despite clinical suspicion, had negative results. The first predated prolactin adjustment, however the other had a low prolactin ratio indicating possible procedural failure and a second BIPSS is planned. Curiously, of the five patients who underwent BIPPS with prolactin measurement, only one met criteria for adequate bilateral cannulation. However, in three of the other four there was a clear central:peripheral ACTH gradient despite a central:peripheral prolactin ratio of <1.8.

BIPSS is a reliable test to confirm Cushing’s disease; we report an 87% success rate over the past 5 years. However, our data sheds some doubt on the reliability of using prolactin to confirm successful BIPSS, as we cannot easily explain a clear central ACTH excess with an apparently ‘non-diagnostic’ test. This merits further study in larger series.

Volume 38

Society for Endocrinology BES 2015

Edinburgh, UK
02 Nov 2015 - 04 Nov 2015

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

No recent abstracts.